ReviewLeukemia2021
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies.
Julia Stomper et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
158 papers cite itlatest 60 shown
this paperpooled ittrialcites it